Oncology Institute Past Earnings Performance
Past criteria checks 0/6
Oncology Institute's earnings have been declining at an average annual rate of -61.2%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been growing at an average rate of 17.8% per year.
Key information
-61.2%
Earnings growth rate
-81.3%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 17.8% |
| Return on equity | -145.7% |
| Net Margin | -20.9% |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Recent updates
Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21
Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth
Mar 16The Oncology Institute: Capitalizing On Clinical Research Contracts
Dec 22Revenue & Expenses BreakdownBeta
How Oncology Institute makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 324 | -68 | 114 | 0 |
| 30 Sep 23 | 310 | -61 | 113 | 0 |
| 30 Jun 23 | 293 | -50 | 117 | 0 |
| 31 Mar 23 | 274 | -40 | 117 | 0 |
| 31 Dec 22 | 252 | 0 | 120 | 0 |
| 30 Sep 22 | 233 | -1 | 137 | 0 |
| 30 Jun 22 | 221 | -2 | 118 | 0 |
| 31 Mar 22 | 210 | 6 | 100 | 0 |
| 31 Dec 21 | 203 | -11 | 83 | 0 |
| 30 Sep 21 | 200 | -6 | 50 | 0 |
| 30 Jun 21 | 195 | -3 | 46 | 0 |
| 31 Mar 21 | 192 | -5 | 44 | 0 |
| 31 Dec 20 | 188 | -14 | 42 | 0 |
| 31 Dec 19 | 155 | -4 | 30 | 0 |
| 31 Dec 18 | 113 | -2 | 17 | 0 |
Quality Earnings: TOI is currently unprofitable.
Growing Profit Margin: TOI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TOI is unprofitable, and losses have increased over the past 5 years at a rate of 61.2% per year.
Accelerating Growth: Unable to compare TOI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TOI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: TOI has a negative Return on Equity (-145.67%), as it is currently unprofitable.